Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.
Ugarte A, De La Mora L, De Lazzari E, Chivite I, Fernández E, Inciarte A, Laguno M, Ambrosioni J, Solbes E, Berrocal L, González-Cordón A, Martínez-Rebollar M, Foncillas A, Calvo J, Blanco JL, Martínez E, Mallolas J, Torres B. Ugarte A, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2343-2353. doi: 10.1093/jac/dkae235. J Antimicrob Chemother. 2024. PMID: 39045754 Clinical Trial.
PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
Laguno M, Ugarte A, Martinez-Rebollar M, Sobrino Y, Font G, de Lazzari E, de la Mora L, Torres B, Chivite I, Riera J, Ambrosioni J, Inciarte A, González-Cordón A, Rojas J, Cordón E, Blanco JL, Martínez E, Mallolas J. Laguno M, et al. Among authors: ugarte a. Enferm Infecc Microbiol Clin (Engl Ed). 2021 May 24:S0213-005X(21)00178-6. doi: 10.1016/j.eimc.2021.04.005. Online ahead of print. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34045097 Free article. English, Spanish.
Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients.
Laguno M, Martínez-Rebollar M, Casanova M, de Lazzari E, González-Cordón A, Torres B, Inciarte A, Mora L, Ugarte A, Ambrosioni J, Blanco JL, Martínez E, Mallolas J. Laguno M, et al. Among authors: ugarte a. Clin Microbiol Infect. 2022 Apr;28(4):610.e1-610.e7. doi: 10.1016/j.cmi.2021.08.019. Epub 2021 Aug 28. Clin Microbiol Infect. 2022. PMID: 34464735 Free article.
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
Garcia-Vidal C, Alonso R, Camon AM, Cardozo C, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, de la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Herrera S, Tuset M, Castro P, Prieto-Gonzalez S, Almuedo-Riera A, Mensa J, Martínez JA, Sanjuan G, Nicolas JM, Del Rio A, Muñoz J, Vila J, Garcia F, Soriano A; Hospital Clinic of Barcelona COVID-19 Research Group. Garcia-Vidal C, et al. J Antimicrob Chemother. 2021 Nov 12;76(12):3296-3302. doi: 10.1093/jac/dkab321. J Antimicrob Chemother. 2021. PMID: 34473275 Free PMC article.
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.
Nomah DK, Reyes-Urueña J, Díaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Llibre JM, Domingo P, Falcó V, Imaz A, Cortés C, Force L, Letang E, Vilaró I, Casabona J, Miro JM; PISCIS study group. Nomah DK, et al. Lancet HIV. 2021 Nov;8(11):e701-e710. doi: 10.1016/S2352-3018(21)00240-X. Epub 2021 Oct 13. Lancet HIV. 2021. PMID: 34655549 Free PMC article.
Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections.
de Lazzari E, Martínez-Mimbrero A, Chivite I, González-Cordón A, Mosquera MM, Laguno M, Costa J, Bosch J, Blanco JL, Álvarez-Martinez M, Ugarte A, Inciarte A, de la Mora L, Torres B, Martínez-Rebollar M, Ambrosioni J, Fernaández E, Hurtado JC, Mallolas J, Miró JM, Marcos MA, Martínez E. de Lazzari E, et al. Among authors: ugarte a. AIDS. 2022 May 1;36(6):829-838. doi: 10.1097/QAD.0000000000003164. Epub 2022 Feb 16. AIDS. 2022. PMID: 35013084
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre.
Ambrosioni J, Rojas Liévano J, Berrocal L, Inciarte A, de la Mora L, González-Cordón A, Martínez-Rebollar M, Laguno M, Torres B, Ugarte A, Chivite I, Leal L, de Lazzari E, Miró JM, Blanco JL, Martinez E, Mallolas J. Ambrosioni J, et al. Among authors: ugarte a. J Antimicrob Chemother. 2022 Mar 31;77(4):1133-1139. doi: 10.1093/jac/dkab481. J Antimicrob Chemother. 2022. PMID: 35040990
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
Camon AM, Alonso R, Muñoz FJ, Cardozo C, Bernal-Maurandi J, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, De la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Rico V, Herrera S, Tuset M, Castro P, Prieto-González S, Almuedo A, Muñoz J, Mensa J, Sanjuan G, Nicolas JM, Del Rio A, Vila J, García F, Martínez JA, Garcia-Vidal C, Soriano A; Hospital Clinic of Barcelona COVID-19 Research Group. Camon AM, et al. Sci Rep. 2022 Mar 28;12(1):5250. doi: 10.1038/s41598-022-08882-x. Sci Rep. 2022. PMID: 35347166 Free PMC article.
176 results